The effect of metformin on lipid disorders as measured by nuclear magnetic metabolomics and metabolic flux analysis
10.16438/j.0513-4870.2020-1774
- VernacularTitle:基于核磁代谢流和代谢组技术对二甲双胍改善脂代谢紊乱作用的研究
- Author:
Qi-feng LIU
;
Xue-qi LÜ
;
Cong-cong GUO
;
Shan-shan SUN
;
Ya-nan WANG
;
Xiang-ju JIN
;
Ying-hong WANG
- Publication Type:Research Article
- Keywords:
hyperlipidemia;
metabolomics;
metabolic flux;
metformin
- From:
Acta Pharmaceutica Sinica
2021;56(4):1109-1119
- CountryChina
- Language:Chinese
-
Abstract:
Studies have found that metformin is not only the preferred drug for lowering blood sugar, but also shows lipid-lowering and weight-loss effects. The purpose of this study was to use a hyperlipidemia hamster model to investigate the lipid-lowering effect of metformin and its effect on important metabolic pathways in lipid metabolism disorders. Fifty golden hamsters were divided into a control group, a model group, metformin high- and low-dose groups, and a simvastatin group. A high-fat diet was fed for 1 week to create the model, and then drug was administered for 11 weeks with the high-fat diet. Serum was taken for measurement of blood lipid and blood glucose at 2, 6, and 9 weeks after administration, and at weeks 3, 5, and 9 feces and urine were collected for 1H NMR metabolomics tests. After 11 weeks of intravenous injection of [U-13C6] glucose, serum was collected for a 13C NMR metabolic flux test. The results showed that the administration of metformin can significantly reduce blood lipids and glucose levels and can significantly affect metabolic pathways such as sugar metabolism, lipid metabolism, ketone metabolism, amino acid metabolism, and intestinal flora metabolism. The results of the metabolic flux analysis showed that the high-fat diet reduced the metabolism of tricarboxylic acids by 37.48%. After administration of low and high doses of metformin the metabolism of tricarboxylic acid increased by 98.14% and 143.10%, respectively. After administration of simvastatin tricarboxylic acid metabolism increased by 33.18%. The results indicate that metformin has a significant effect on promoting energy metabolism. This study used a combination of metabolomics and metabolic flow to explore the effect of metformin on lipid metabolism disorders and quantifies changes in the key pathway of energy metabolism-the tricarboxylic acid cycle. This study provides useful information for the study of the efficacy and mechanism of metformin, as well as a practical technical method for the screening of lipid-lowering drugs based on a hamster model.
